2024 Affordable Care Act Marketplace Plan Selections by Congressional District InteractiveMay 2, 2024 2024 Affordable Care Act Marketplace Plan Selections by Congressional District A new CAP interactive explores the proportion of nonelderly people who made federally facilitated marketplace plan selections during the 2024 open enrollment period by congressional district. Without congressional action, consumers will lose the enhanced financial assistance that supported record levels of enrollment. May 2, 2024 Nicole Rapfogel
Monthly Medicare Drug Price Negotiation Savings by State InteractiveApr 2, 2024 Monthly Medicare Drug Price Negotiation Savings by State Medicare drug price negotiation will result in thousands of dollars in net price savings for 30-day supplies of the first 10 drugs undergoing negotiation; here’s how those savings add up state by state. Apr 2, 2024 Nicole Rapfogel
5 Things To Know About Pharmacy Benefit Managers ArticleMar 13, 2024 5 Things To Know About Pharmacy Benefit Managers Pharmacy benefit managers are pharmaceutical middlemen that can inflate prescription drug costs for insurers and consumers. Mar 13, 2024 Nicole Rapfogel
Medicare Drug Price Negotiation Will Lower Prices by Thousands of Dollars per Month ArticleFeb 21, 2024 Medicare Drug Price Negotiation Will Lower Prices by Thousands of Dollars per Month A new analysis estimates prices for 30-day supplies of the first 10 Medicare Part D drugs undergoing price negotiations, with monthly reductions as high as $6,500 for some drugs. Feb 21, 2024 Nicole Rapfogel
Obamacare Has Been a Success, and It’s Just the Start In the NewsFeb 16, 2024 Obamacare Has Been a Success, and It’s Just the Start Nicole Rapfogel writes in The Ripon Forum about the benefits of the Affordable Care Act. Feb 16, 2024 The Ripon Forum Nicole Rapfogel
The Employer Public Option: A Tool for Improving Affordability via Alternative Health Coverage ReportJan 25, 2024 The Employer Public Option: A Tool for Improving Affordability via Alternative Health Coverage This report offers policy principles for employer public option reform to help reduce the cost of employer-sponsored insurance; lower health care prices; and increase workers’ access to affordable, comprehensive coverage. Jan 25, 2024 Natasha Murphy, Sam Hughes, Nicole Rapfogel
Federal Solutions To Address Rising Costs of Employer-Sponsored Insurance ReportJan 25, 2024 Federal Solutions To Address Rising Costs of Employer-Sponsored Insurance Federal policymakers should act to lower health insurance costs and improve affordability for both employers and workers. Jan 25, 2024 Sam Hughes, Nicole Rapfogel, Emily Gee
Drug Companies Continue To Hike Prices Above Inflation ArticleNov 1, 2023 Drug Companies Continue To Hike Prices Above Inflation New analysis makes clear that the Inflation Reduction Act’s inflation rebates should extend to the commercial market. Nov 1, 2023 Nicole Rapfogel
Following the Money: Untangling U.S. Prescription Drug Financing ReportOct 12, 2023 Following the Money: Untangling U.S. Prescription Drug Financing This report discusses how money flows through the pharmaceutical ecosystem and how policymakers should address high prices. Oct 12, 2023 Sam Hughes, Nicole Rapfogel
5 Facts To Know About Medicare Drug Price Negotiation ArticleAug 30, 2023 5 Facts To Know About Medicare Drug Price Negotiation Price negotiation will improve access and affordability for Medicare Part D drugs for seniors. Aug 30, 2023 Nicole Rapfogel
Medicare Drug Price Negotiation Will Help Millions of Seniors and Improve Health Equity ArticleJul 17, 2023 Medicare Drug Price Negotiation Will Help Millions of Seniors and Improve Health Equity The Inflation Reduction Act’s Medicare drug price negotiation provision will improve access to and affordability of medications that help women, Black, Hispanic or Latino, LGBTQI+, and disabled beneficiaries. Jul 17, 2023 Gillian Tisdale, Nicole Rapfogel
Medicare Drug Price Negotiation Could Benefit Millions of Seniors ArticleApr 26, 2023 Medicare Drug Price Negotiation Could Benefit Millions of Seniors The first 10 drugs negotiated under the Inflation Reduction Act are likely to include treatments for chronic conditions—such as diabetes, cancer, and autoimmune disorders—and be used by millions of beneficiaries. Apr 26, 2023 Nicole Rapfogel